Search results
Your search for ���������������������������������������������:kn39��� returned no results
Showing 1 to 15 of 813 results for ���������������������������������������������:know���
Showing 1 to 15 of 813 results for ���������������������������������������������:know���
Supporting the health and care system to implement virtual wards
Ensure that the person using intermediate care and their family and carers know who to speak to if they have any questions or concerns...
How we collect and use your personal information, and your rights under data protection legislation
Home testing devices could increase the number of people diagnosed with sleep condition
Five home-testing devices to diagnose a silent sleep condition seriously harming the health of an estimated 2.5 million adults have been recommended by NICE in draft guidance.
Remdesivir and tixagevimab plus cilgavimab for treating COVID-19 (TA971)
Evidence-based recommendations on remdesivir (Veklury) and tixagevimab plus cilgavimab (Evusheld) for treating COVID-19.
This guideline covers managing COVID-19 in babies, children, young people and adults in community and hospital settings. It includes recommendations on communication, assessment, therapeutics for COVID-19, non-invasive respiratory support, preventing and managing acute complications, and identifying and managing co-infections.
a letter or email to tell you. If you're not successful, we will let you know too. Who we're looking for We welcome applicants from all...
Evidence-based recommendations on selinexor (Nexpovio) with dexamethasone for treating relapsed or refractory multiple myeloma after 4 or more treatments in adults.
Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma (TA540)
Evidence-based recommendations on pembrolizumab (Keytruda) for treating relapsed or refractory classical Hodgkin lymphoma in adults.
Evidence-based recommendations on pembrolizumab (Keytruda) for relapsed or refractory classical Hodgkin lymphoma in people 3 years and over.
Tell us about an interventional procedure you think should be assessed by NICE.
Dabrafenib with trametinib is a targeted treatment that can be taken at home rather than hospital and improves the length and quality of life for patients.
This guideline covers diagnosing and managing endometriosis. It aims to raise awareness of the symptoms of endometriosis, and to provide clear advice on what action to take when women and people with signs and symptoms first present in healthcare settings. It also provides advice on the range of treatments available.
Cabozantinib with nivolumab for untreated advanced renal cell carcinoma (TA964)
Evidence-based recommendations on cabozantinib (Cabometyx) with nivolumab (Opdivo) for untreated advanced renal cell carcinoma in adults.
This guideline covers care for pregnant women and pregnant people with a twin or triplet pregnancy in addition to routine care during pregnancy and labour. It aims to reduce the risk of complications and improve outcomes.
A range of fictional scenarios which show how NICE's guidelines and quality standards could be used by social workers in different settings.